EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Ligand‐Based Pharmacophore Modeling and Structure‐Based Virtual Screening for Identifying Potential Therapeutic Agents Targeting the SARS‐CoV‐2 Spike Protein‐ACE2 Receptor Interaction

Timoteo Delgado-Maldonado, Gilberto Vargas-Salas, Debasish Bandyopadhyay, Adriana Moreno-Rodríguez, Eyra Ortiz-Pérez, Gildardo Rivera iD

ChemMedChem · 2026

DOI: 10.1002/cmdc.70311 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, 2026. Verfasst von Timoteo Delgado-Maldonado und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Biotecnología Farmacéutica, Centro de Biotecnología Genómica, Instituto Politécnico Nacional, Reynosa, México. Hauptthemen laut MEDLINE: Spike Glycoprotein, Coronavirus, SARS-CoV-2, Antiviral Agents, Angiotensin-Converting Enzyme 2. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Secretaría de Investigación y Posgrado, Instituto Politécnico Nacional, SIP, IPN.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Coronavirus disease (COVID‐19) remains a global health concern due to its high mortality and morbidity. In this study, we combined ligand‐based pharmacophore modeling (LBPM) with structure‐based virtual screening (SBVS) to identify novel inhibitors targeting the SARS‐CoV‐2 spike protein. Ligands from the MolPort database were screened via docking and molecular dynamics simulations at the receptor‐binding domain (RBD). Four compounds showed promising docking scores (–8.7 to –6.4 kcal/mol) and dynamic stability (root mean square deviation < 5 Å). In vitro assays confirmed that compounds C3 (IC 50 = 0.03 µM) and C4 (IC 50 = 10.4 µM) effectively inhibited spike–ACE2 binding with low cytotoxicity (CC 50 > 100 µM). These findings show the efficacy of the LBPM technique and highlight 1H‐pyrazol‐5‐ol derivatives as potential building blocks for developing new antiviral agents against SARS‐CoV‐2.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spike Glycoprotein, CoronavirusSARS-CoV-2Antiviral AgentsAngiotensin-Converting Enzyme 2PharmacophoreHumansLigandsMolecular Docking SimulationMolecular Dynamics SimulationDrug Evaluation, PreclinicalProtein BindingStructure-Activity RelationshipBetacoronavirus

Stichwörter der Autor:innen

1H‐pyrazol‐5‐ol derivativesSARS‐CoV‐2 spike proteininhibitors viral entrypharmacophore modeling validation

Substanzen

Spike Glycoprotein, CoronavirusAntiviral Agentsspike protein, SARS-CoV-2Angiotensin-Converting Enzyme 2LigandsACE2 protein, human

Autor:innen und Institutionen

  • Laboratorio de Biotecnología Farmacéutica, Centro de Biotecnología Genómica, Instituto Politécnico Nacional, Reynosa, México.
  • School of Integrative Biological and Chemical Sciences (SIBCS) & School of Earth, Environmental, and Marine Sciences (SEEMS), University of Texas Rio Grande Valley, Edinburg, Texas, USA.
  • Laboratorio de estudios Epidemiológicos, Clínicos, Diseños Experimentales e Investigación, Facultad de ciencias Químicas, Universidad Autónoma "Benito Juárez" de Oaxaca, Oaxaca, México.

ORCID-Profile: Gildardo Rivera

Förderung

  • Secretaría de Investigación y Posgrado, Instituto Politécnico Nacional
  • SIP, IPN

Zitieren

APA

Delgado-Maldonado, T., Vargas-Salas, G., Bandyopadhyay, D., Moreno-Rodríguez, A., Ortiz-Pérez, E., & Rivera, G. (2026). Ligand‐Based Pharmacophore Modeling and Structure‐Based Virtual Screening for Identifying Potential Therapeutic Agents Targeting the SARS‐CoV‐2 Spike Protein‐ACE2 Receptor Interaction. ChemMedChem. https://doi.org/10.1002/cmdc.70311

Vancouver

Delgado-Maldonado T, Vargas-Salas G, Bandyopadhyay D, Moreno-Rodríguez A, Ortiz-Pérez E, Rivera G. Ligand‐Based Pharmacophore Modeling and Structure‐Based Virtual Screening for Identifying Potential Therapeutic Agents Targeting the SARS‐CoV‐2 Spike Protein‐ACE2 Receptor Interaction. ChemMedChem. 2026. doi:10.1002/cmdc.70311

BibTeX
@article{DelgadoMaldonado2026,
  author = {Delgado-Maldonado, Timoteo and Vargas-Salas, Gilberto and Bandyopadhyay, Debasish and Moreno-Rodríguez, Adriana and Ortiz-Pérez, Eyra and Rivera, Gildardo},
  title = {Ligand‐Based Pharmacophore Modeling and Structure‐Based Virtual Screening for Identifying Potential Therapeutic Agents Targeting the SARS‐CoV‐2 Spike Protein‐ACE2 Receptor Interaction},
  journal = {ChemMedChem},
  year = {2026},
  doi = {10.1002/cmdc.70311}
}
Kostenlos starten →